Matthew Rubach
Associate Professor, Medicine
Associate Research Professor, Global Health
Appointment:
Topics:
Countries:
Matthew Rubach
Associate Professor, Medicine
Associate Research Professor, Global Health
Matthew Rubach, MD is a specialist in clinical infectious diseases with medical specialty training in Pediatrics, Internal Medicine and Medical Microbiology. Since November 2015, he has been based full-time as a clinical researcher and clinician in Moshi, Tanzania where he serves as Co-Director of the Kilimanjaro Christian Medical Centre (KCMC)-Duke Health Collaboration. He conducts clinical research on causes of severe febrile illness, sepsis management, vascular pathology of severe malaria, and zoonotic disease epidemiology. In addition to clinical research, he serves as Medical Director of the laboratory that supports clinical investigation at KCMC and he provides medical care & training in the HIV clinic and Medical Ward of KCMC.
His primary appointment is Associate Professor in the Department of Medicine, Division of Infectious Diseases & International Health, with a joint appointment to the Duke Global Health Institute and an adjunct appointment at Duke-National University of Singapore Medical School’s Programme in Emerging Infectious Diseases.
Dr. Rubach holds a Bachelor of Arts from Princeton University. He received his Doctor of Medicine from the University of Arizona, and then went on to complete specialty training in a combined Internal Medicine-Pediatrics residency program at the University of Utah. He completed adult sub-specialty fellowship training in Infectious Diseases at Duke University, followed by a capstone fellowship in Clinical Pathology-Medical Microbiology at the University of Utah. He has board certification from the American Board of Pediatrics (2011-2021) and is actively maintaining his board certifications from the American Board of Internal Medicine (General Medicine and Infectious Diseases) and the American Board of Pathology (Medical Microbiology).
Projects
-
Sepsis Characterization in Kilimanjaro (SICK)
Tanzania
-
Viral Zoonoses and Severe Febrile Illness in northern Tanzania
Tanzania
-
Investigating Febrile Deaths in Tanzania
Tanzania
-
Nitric Oxide and Microvascular Dysfunction in Severe Malaria
Tanzania
-
Molecular Epidemiology of Brucellosis in Northern Tanzania
Tanzania
-
International Maternal Pediatric Adolescent AIDS Clinical Trials
Tanzania
Publications
-
Villa S, Carugati M, Rubach MP, Cleaveland S, Mpagama SG, Khan SS, et al. 'One Health´ approach to end zoonotic TB. Int J Tuberc Lung Dis. 2023 Feb 1;27(2):101–5.Hertz JT, Prattipati S, Kweka GL, Mlangi JJ, Tarimo TG, Mmbaga BT, et al. Prevalence and predictors of uncontrolled hypertension, diabetes, and obesity among adults with HIV in northern Tanzania. Glob Public Health. 2022 Dec;17(12):3747–59.de Glanville WA, Allan KJ, Nyarobi JM, Thomas KM, Lankester F, Kibona TJ, et al. An outbreak of Rift Valley fever among peri-urban dairy cattle in northern Tanzania. Trans R Soc Trop Med Hyg. 2022 Nov 1;116(11):1082–90.de Glanville WA, Nyarobi JM, Kibona T, Halliday JEB, Thomas KM, Allan KJ, et al. Inter-epidemic Rift Valley fever virus infection incidence and risks for zoonotic spillover in northern Tanzania. Plos Negl Trop Dis. 2022 Oct;16(10):e0010871.
See more publications at Scholars@Duke